Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Solid, Hematological Malignancies Show Different Responses to Zoster Vaccines Solid, Hematological Malignancies Show Different Responses to Zoster Vaccines
Inactivated varicella zoster virus (VZV) vaccine elicits protective responses in immunosuppressed patients with solid tumor malignancies, whereas patients with hematological malignancies respond to adjuvanted recombinant zoster vaccine, according to a pair of new studies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Can A Vaccine Help Reduce Herpes Zoster After ASCT?
Researchers looked at whether or not a two-dose recombinant zoster vaccine would reduce the incidence of herpes zoster in patients with hematologic malignancies after autologous stem cell transplantation. (Source: CancerNetwork)
Source: CancerNetwork - July 16, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Two - Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
Incidence of herpes zoster decreased during median 21 - month follow - up after autologous HSCT (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 10, 2019 Category: Cancer & Oncology Tags: Infections, Oncology, Pharmacy, Journal, Source Type: news

Two-Dose Course of Vaccine After HSCT Cuts Incidence of Zoster
WEDNESDAY, July 10, 2019 -- A two-dose course of recombinant zoster vaccine is associated with a reduction in the incidence of herpes zoster among adults who have undergone autologous hematopoietic stem cell transplantation (HSCT), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 10, 2019 Category: Pharmaceuticals Source Type: news

Shingrix cost effective versus Zostavax in Canada
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 30, 2019 Category: Drugs & Pharmacology Source Type: news

2003 to 2014 Saw Incidence of Herpes Zoster Drop in Children
MONDAY, June 10, 2019 -- From 2003 to 2014, there was a decrease in herpes zoster (HZ) incidence among children, with lower incidence rates for varicella-vaccinated versus unvaccinated children, according to a study published online June 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 10, 2019 Category: Pharmaceuticals Source Type: news

Mayo Clinic Minute: What are eye shingles?
Shingles is caused by the varicella-zoster virus -- the same virus that causes chickenpox. If you've had chickenpox, the virus can lie dormant in your body's nerve tissue for years when suddenly it's triggered by stress or a weakened immune system, and manifests as shingles. A new shingles vaccine called Shingrix is recommended for anyone [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 14, 2019 Category: Databases & Libraries Source Type: news

Zostavax (Zoster Vaccine Live) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 18, 2019 Category: Drugs & Pharmacology Source Type: news

Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)
Title: Shingles Vaccine (Zoster Shingles Vaccine Live, Zostavax)Category: MedicationsCreated: 11/9/2010 12:00:00 AMLast Editorial Review: 3/13/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 13, 2019 Category: Dermatology Source Type: news

Postlicensure Safety Surveillance of Shingrix Postlicensure Safety Surveillance of Shingrix
Are early safety monitoring findings for recombinant zoster vaccine (Shingrix) consistent with prelicensure clinical trial data?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

Recombinant Zoster Vaccine Cost-Effective in Simulation
TUESDAY, Feb. 19, 2019 -- Vaccination with recombinant zoster vaccine (RZV) seems cost-effective under a wide range of conditions, according to a study published online Feb. 19 in the Annals of Internal Medicine. Lisa A. Prosser, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 19, 2019 Category: Pharmaceuticals Source Type: news

CDC Examines Safety of Recombinant Zoster Vaccine
MONDAY, Feb. 4, 2019 -- During the first eight months of recombinant zoster vaccine (RZV) use, there were reports of 4,381 adverse events, 3 percent of which were serious, according to research published in the Feb. 1 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2019 Category: Pharmaceuticals Source Type: news

Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk Post-Onset Shingles Rx Fails to Cut Ischemic Stroke Risk
The higher risk for stroke with herpes zoster was not attenuated by antivirals or Zostavax vaccination in older patients, but that shouldn ' t slow vaccination rates or further study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Update: Common Shingrix Reactions--Which Can Be Prevented? Update: Common Shingrix Reactions--Which Can Be Prevented?
If administered incorrectly, Shingrix can produce some painful local reactions. Make sure your staff knows the differences between the two herpes zoster vaccines.CDC Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Infectious Diseases Commentary Source Type: news

Early Surveillance Data Confirm Safety of Shingrix Vaccine Early Surveillance Data Confirm Safety of Shingrix Vaccine
New research from the CDC confirms the safety of the Shingrix recombinant zoster vaccine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news